DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
The post DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace